Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lymphopenia in Cancer Patients and its Effects on Response to Immunotherapy: an opportunity for combination with Cytokines?
Christine Ménétrier‐Caux, Isabelle Ray‐Coquard, Jean‐Yves Blay, et al.
Journal for ImmunoTherapy of Cancer (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 262

Showing 1-25 of 262 citing articles:

Immunogenic cell stress and death
Guido Kroemer, Claudia Galassi, Laurence Zitvogel, et al.
Nature Immunology (2022) Vol. 23, Iss. 4, pp. 487-500
Open Access | Times Cited: 870
COVID-19 and Cancer: a Comprehensive Review
Rohit Gosain, Yara Abdou, Abhay Singh, et al.
Current Oncology Reports (2020) Vol. 22, Iss. 5
Open Access | Times Cited: 291
Hyperprogressive disease during PD-1 blockade in patients with advanced hepatocellular carcinoma
Chang Gon Kim, Chan Kim, Sang Eun Yoon, et al.
Journal of Hepatology (2020) Vol. 74, Iss. 2, pp. 350-359
Closed Access | Times Cited: 156
Combining antibody-drug conjugates with immunotherapy in solid tumors: current landscape and future perspectives
Eleonora Nicolò, Federica Giugliano, Liliana Ascione, et al.
Cancer Treatment Reviews (2022) Vol. 106, pp. 102395-102395
Closed Access | Times Cited: 126
COVID-19 vaccines for patients with cancer: benefits likely outweigh risks
Joyce K. Hwang, Tian Zhang, Andrew Z. Wang, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 122
Reshaping the systemic tumor immune environment (STIE) and tumor immune microenvironment (TIME) to enhance immunotherapy efficacy in solid tumors
Liangliang Xu, Chang Zou, Shanshan Zhang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 115
The expanding role for small molecules in immuno-oncology
Rienk Offringa, Lisa Kötzner, Bayard R. Huck, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 11, pp. 821-840
Closed Access | Times Cited: 86
Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors
Levente Zsichla, Viktor Müller
Viruses (2023) Vol. 15, Iss. 1, pp. 175-175
Open Access | Times Cited: 71
Injectable supramolecular hydrogel co-loading abemaciclib/NLG919 for neoadjuvant immunotherapy of triple-negative breast cancer
Binyu Zhu, Ying Cai, Lingli Zhou, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
The immuno-oncological challenge of COVID-19
Lisa Derosa, Cléa Melenotte, Frank Griscelli, et al.
Nature Cancer (2020) Vol. 1, Iss. 10, pp. 946-964
Open Access | Times Cited: 117
Interaction between lymphopenia, radiotherapy technique, dosimetry, and survival outcomes in lung cancer patients receiving combined immunotherapy and radiotherapy
Dawei Chen, Roshal R. Patel, Vivek Verma, et al.
Radiotherapy and Oncology (2020) Vol. 150, pp. 114-120
Closed Access | Times Cited: 90
Lymphocyte-Sparing Radiotherapy: The Rationale for Protecting Lymphocyte-rich Organs When Combining Radiotherapy With Immunotherapy
Philippe Lambin, R. Lieverse, Franziska Eckert, et al.
Seminars in Radiation Oncology (2020) Vol. 30, Iss. 2, pp. 187-193
Open Access | Times Cited: 85
Lymphopenia Caused by Virus Infections and the Mechanisms Beyond
Zijing Guo, Zhidong Zhang, Meera Prajapati, et al.
Viruses (2021) Vol. 13, Iss. 9, pp. 1876-1876
Open Access | Times Cited: 85
Evaluation of COVID-19 vaccine response in patients with cancer: An interim analysis
Son Tran, Tony H. Truong, Aru Narendran
European Journal of Cancer (2021) Vol. 159, pp. 259-274
Open Access | Times Cited: 65
Risk and impact of radiation related lymphopenia in lung cancer: A systematic review and meta-analysis
Rituraj Upadhyay, Bhanu Prasad Venkatesulu, Prashanth Giridhar, et al.
Radiotherapy and Oncology (2021) Vol. 157, pp. 225-233
Closed Access | Times Cited: 64
The immune modifying effects of chemotherapy and advances in chemo-immunotherapy
Daniel R. Principe, Suneel D. Kamath, Murray Korc, et al.
Pharmacology & Therapeutics (2022) Vol. 236, pp. 108111-108111
Open Access | Times Cited: 45
Blood biomarkers predict outcomes in patients with hepatocellular carcinoma treated with immune checkpoint Inhibitors: A pooled analysis of 44 retrospective sudies
Lilong Zhang, Jiarui Feng, Tianrui Kuang, et al.
International Immunopharmacology (2023) Vol. 118, pp. 110019-110019
Open Access | Times Cited: 35
Immunotherapy Approaches for Breast Cancer Patients in 2023
Leisha A. Emens, Sherene Loi
Cold Spring Harbor Perspectives in Medicine (2023) Vol. 13, Iss. 4, pp. a041332-a041332
Open Access | Times Cited: 33
Systemic and local immunosuppression in glioblastoma and its prognostic significance
Aleksei A. Stepanenko, Anastasiia O. Sosnovtseva, M. P. Valikhov, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Early effects of different brain radiotherapy modalities on circulating leucocyte subpopulations in rodents
Thao-Nguyen Pham, Julie Coupey, Jérôme Toutain, et al.
International Journal of Radiation Biology (2024) Vol. 100, Iss. 5, pp. 744-755
Open Access | Times Cited: 10
SARS-CoV-2-associated lymphopenia: possible mechanisms and the role of CD147
Shaimaa Shouman, Nada Elkholy, Alaa E. Hussien, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 9
Impact of circulating lymphocyte kinetics following radiotherapy on patient survival: A model-based meta-analysis
Thao-Nguyen Pham, Julie Coupey, Juliette Thariat, et al.
Computers in Biology and Medicine (2025) Vol. 186, pp. 109702-109702
Open Access | Times Cited: 1
Simultaneous integrated dose reduction intensity-modulated radiotherapy improves survival in patients with locally advanced non-small cell lung cancer by reducing cardiac irradiation exposure
Chang Xu, Jiehan Wu, Bingxin Liu, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Immunotherapy in People With HIV and Cancer
Camille E. Puronen, Emily S. Ford, Thomas S. Uldrick
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 57
Decreased Absolute Lymphocyte Count and Increased Neutrophil/Lymphocyte Ratio With Immune Checkpoint Inhibitor–Associated Myocarditis
Zsófia D. Drobni, Amna Zafar, Leyre Zubiri, et al.
Journal of the American Heart Association (2020) Vol. 9, Iss. 23
Open Access | Times Cited: 56
Page 1 - Next Page

Scroll to top